Our Team

Edwin Kim, MD
Medical Director

Dr. Kim is the medical director of the Charles O’Brien Center for Addiction Treatment at the University of Pennsylvania Health System and provides services at Penn Medicine’s Perinatal Center of Excellence, also known as Mothers Matter, in collaboration with the Penn Presbyterian Medical Center and Maternity Care Coalition. He holds board-certification in both Psychiatry and Addiction Psychiatry.  He specializes in evaluating and treating substance use disorders, as well as co-occurring substance use and psychiatric disorders, including depression, anxiety, and ADHD. He also teaches medical students, residents and fellows on faculty at the University of Pennsylvania, as an assistant professor of clinical psychiatry. After a career in bioinformatics and genomic science at the Department of Energy’s Joint Genome Institute, he completed medical school at Saint George’s University, residency at the Creighton University School of Medicine, Phoenix Campus in Arizona, and fellowship in addiction psychiatry at the University of Pennsylvania.

Dr. Kim’s principal goal is to provide individuals with comprehensive, personalized care. He strives for meaningful and measurable results by incorporating a patient-driven decision-making process. His clinical care is empathetic, non-judgmental, and respectful. He is dedicated to assisting individuals find their path into recovery, and to maintain sustainable results.

Shazia Savul, MD



Martin D. Cheatle, PhD


Dr. Cheatle earned his PhD in psychology at Princeton University. He completed his clinical internship at the University of Pennsylvania, School of Medicine and founded the Orthopaedic Pain Center at PENN. Currently he is Director of Behavioral Medicine at the PENN Pain Medicine Center and Director, Pain and Chemical Dependency Research at the Center for Studies of Addiction. He is an Associate Professor of Psychiatry at the Perelman School of Medicine, University of Pennsylvania.  Dr. Cheatle specializes in the evaluation and treatment of chronic pain disorders from a biopsychosocial perspective and has been involved in extensive research including a NIH funded 5-year longitudinal study of the development of opioid use disorders in patients initiating prescription opioid therapy for chronic pain and as PI of a NIH/NIDA grant assessing phenotypic and genotypic markers of prescription opioid use disorder in patients with chronic pain. His main focus of research is pain management and substance use disorders in vulnerable populations (HIV/AIDS, psychiatric patients) and pain and suicidal ideation and behavior. Clinically, he specializes in assessing and treating patients with chronic pain and a co-occurring substance use disorder providing non-pharmacologic interventions to improve pain, function and mood and decreasing the potential of relapse.

James McKay, PhD

Anaya Kellogg, LCSW

Anaya Kellogg

Anaya Kellogg (Erika Anaya Kellogg) is a Licensed Clinical Social Worker at the Penn Outpatient Psychiatry Center and at the Charles O'Brien Center for Addiction Treatment.  Anaya also serves as the Director and Educational Supervisor for the DBT Training Program in the Department of Psychiatry at Penn Medicine.  Anaya is a board certified DBT Clinician through the DBT-Linehan board of Certification. Anaya also holds the Advanced Alcohol and Drug Counseling designation through the Pennsylvania Certification Board.  Anaya primarily works with adults experiencing suicidal ideation, non-suicidal self-injury and substance us disorders.  In treatment she uses a variety of therapeutic approaches including Dialectical Behavioral Therapy (DBT), Cognitive Behavioral Therapy (CBT) and Motivational Interviewing.


Back to Top